ArticleMolecular cancer therapeutics2023

Nifuroxazide Activates the Parthanatos to Overcome TMPRSS2:ERG Fusion-Positive Prostate Cancer.

Chengxun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.